Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria

Overview of attention for article published in Cardiovascular Diabetology, July 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 44 Dimensions

Readers on

mendeley: 63 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 604 followers.

RT @FrederikPersson: ADMA/SDMA as markers of CVD, mortality and kidney function decline in #type2diabetes from @Stenodiabetes https://t.co/…

Reply Repost Favourite

RT @FrederikPersson: ADMA/SDMA as markers of CVD, mortality and kidney function decline in #type2diabetes from @Stenodiabetes https://t.co/…

Reply Repost Favourite

ADMA/SDMA as markers of CVD, mortality and kidney function decline in #type2diabetes from @Stenodiabetes https://t.co/21EOmSBiKb

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.